FDA and the safe and appropriate antibiotic use of fluoroquinolones

被引：8

作者：

Tillotson, Glenn S. ^{[1
]}

机构：

[1] GST Micro LLC, Downingtown, PA 19335 USA

来源：

关键词：

D O I：

10.1016/S1473-3099(16)00051-7

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：E11 / E12

页数：2

相关论文

共 1 条

[1] US Food and Drug Administration, 2015, JOINT M ANT DRUGS AD, DOI [13044503/http:/www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM475246.pdf, DOI 13044503/HTTP:/WWW.FDA.GOV/DOWNLOADS/ADVISORYCOMMITTEES/COMMITTEESMEETINGMATERIALS/DRUGS/ANTI-INFECTIVEDRUGSADVISORYCOMMITTEE/UCM475246.PDF]